3rd Quarter - Report
DLA PIPER LLP (US) for HUMACYTE, INC.
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL SORENSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.